Statin use is associated with reduction in risk of de novo primary sclerosing cholangitis among patients with inflammatory bowel disease: A National Database Study
View ORCID ProfileChiraag Kulkarni, John Gubatan, C. William Pike, Gavin Hui, Saurabh Gombar, Jennifer Kramer, Michael L. Jackson, Aparna Goel, John Vierling, George Cholankeril, Sidhartha R. Sinha
doi: https://doi.org/10.1101/2024.09.17.24313852
Chiraag Kulkarni
1Division of Gastroenterology & Hepatology, Department of Medicine, Stanford University, Palo Alto, California
MDJohn Gubatan
1Division of Gastroenterology & Hepatology, Department of Medicine, Stanford University, Palo Alto, California
MDC. William Pike
2Atropos Health, Palo Alto, California
MDGavin Hui
2Atropos Health, Palo Alto, California
MDSaurabh Gombar
2Atropos Health, Palo Alto, California
MD, PhDJennifer Kramer
3Section of Gastroenterology & Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas
MPH, PhDMichael L. Jackson
2Atropos Health, Palo Alto, California
PhD, MPHAparna Goel
1Division of Gastroenterology & Hepatology, Department of Medicine, Stanford University, Palo Alto, California
MDJohn Vierling
3Section of Gastroenterology & Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas
MDGeorge Cholankeril
3Section of Gastroenterology & Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas
MDSidhartha R. Sinha
1Division of Gastroenterology & Hepatology, Department of Medicine, Stanford University, Palo Alto, California
MDData Availability
All data produced in the present study are available upon reasonable request to the authors
Posted September 19, 2024.
Statin use is associated with reduction in risk of de novo primary sclerosing cholangitis among patients with inflammatory bowel disease: A National Database Study
Chiraag Kulkarni, John Gubatan, C. William Pike, Gavin Hui, Saurabh Gombar, Jennifer Kramer, Michael L. Jackson, Aparna Goel, John Vierling, George Cholankeril, Sidhartha R. Sinha
medRxiv 2024.09.17.24313852; doi: https://doi.org/10.1101/2024.09.17.24313852
Statin use is associated with reduction in risk of de novo primary sclerosing cholangitis among patients with inflammatory bowel disease: A National Database Study
Chiraag Kulkarni, John Gubatan, C. William Pike, Gavin Hui, Saurabh Gombar, Jennifer Kramer, Michael L. Jackson, Aparna Goel, John Vierling, George Cholankeril, Sidhartha R. Sinha
medRxiv 2024.09.17.24313852; doi: https://doi.org/10.1101/2024.09.17.24313852
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (197)
- Cardiovascular Medicine (2881)
- Dermatology (247)
- Emergency Medicine (432)
- Epidemiology (12617)
- Forensic Medicine (10)
- Gastroenterology (812)
- Genetic and Genomic Medicine (4482)
- Geriatric Medicine (409)
- Health Economics (717)
- Health Informatics (2868)
- Health Policy (1059)
- Hematology (378)
- HIV/AIDS (910)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4244)
- Nursing (228)
- Nutrition (622)
- Oncology (2225)
- Ophthalmology (633)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (490)
- Pediatrics (1182)
- Primary Care Research (487)
- Public and Global Health (6829)
- Radiology and Imaging (1502)
- Respiratory Medicine (908)
- Rheumatology (430)
- Sports Medicine (376)
- Surgery (475)
- Toxicology (60)
- Transplantation (206)
- Urology (176)